X

Health Care

WBA Earnings: Walgreens Boots Alliance Q2 profit and sales beat estimates

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net…

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the…

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on…

LatAm healthcare firm Auna prepares for NYSE listing; to raise $420 million in IPO

IPO activity gathered momentum this year in a sign that the market is recovering from the weakness experienced in 2023.…

Earnings Summary: CooperCompanies (COO) reports strong Q1 2024 results

Medical device maker CooperCompanies (NYSE: COO) announced financial results for the first quarter of 2024, reporting an increase in revenues…

Earnings Summary: Dentsply Sirona reports higher sales for Q4 2023

Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting…

Earnings: Agilent’s (A) Q1 2024 profit declines on lower revenues

Healthcare company Agilent Technologies Inc. (NYSE: A) reported a decrease in adjusted earnings for the first quarter of 2024 when…

Infographic: Highlights of Moderna’s (MRNA) Q4 2023 earnings results

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) reported a sharp decline in revenues and earnings for the fourth quarter of 2023.…

Medtronic (MDT) Q3 2024 revenue rises 5%; adj. earnings flat

Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues for the third quarter of 2024 when the…

Earnings Summary: Organon reports financial results for Q4 2023

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the fourth quarter of 2023.…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers and institutions to accelerate the development…

BIIB Earnings: Here’s everything you need to know about Biogen’s Q4 report

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the fourth quarter of…

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy…

Earnings Summary: Baxter International reports higher Q4 sales and adj. profit

Medical device maker Baxter International Inc. (NYSE: BAX) has announced financial results for the fourth quarter of 2023, reporting higher…

CVS Health Q4 2023 adj. earnings rise on higher revenues; guides FY24

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced fourth-quarter 2023 results, reporting higher revenues and adjusted earnings. December quarter adjusted…

Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results

Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a…

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter…

Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for…

Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today. Total revenues inched up 1% to $11.5 billion…

ABBV Earnings: Everything you need to know about AbbVie’s Q4 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The…

Eli Lilly and Company all set to report Q4 results. Here’s what to expect

Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully…